The jury verdict against Teva Pharmaceuticals USA Inc. in New York state’s opioid trial shows the significant liability opioid makers face despite victories in the only other two cases that have reached trial decisions and may impact global settlement discussions that have been bogged down for the past two years.
After a six-month trial, a six-member jury issued a verdict on 30 December, finding that Teva and its affiliates and...